Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NPRL2 down‐regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression
Ya‐Chin Wang, Ming‐Chao Tsai, Yaw‐Sen Chen, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3563-3577
Open Access | Times Cited: 14

Showing 14 citing articles:

NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song, et al.
eLife (2025) Vol. 13
Open Access
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products
Guo Chen, Ya Zhang, Y.‐H. Zhou, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 10421-10440
Open Access | Times Cited: 2
Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds
Canhui Jin, Tianbao Wang, Yanhui Yang, et al.
Environmental Research (2023) Vol. 227, pp. 115721-115721
Closed Access | Times Cited: 4
Lysosome-related genes: A new prognostic marker for lung adenocarcinoma
Zeyang Hu, Hang Chen, Hongxiang Li, et al.
Medicine (2023) Vol. 102, Iss. 35, pp. e34844-e34844
Open Access | Times Cited: 3
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Reviewer #3 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model

(2024)
Open Access
Reviewer #1 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model

(2024)
Open Access
Reviewer #2 (Public Review): NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model

(2024)
Open Access
eLife assessment: NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Jia Wei
(2024)
Open Access
Author response: NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song, et al.
(2024)
Open Access
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song, et al.
(2024)
Open Access
NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model
Ismail M. Meraz, Mourad Majidi, Renduo Song, et al.
eLife (2024)
Open Access
NPRL2 promotes TRIM16-mediated ubiquitination degradation of Galectin-3 to prevent CD8+T lymphocyte cuproptosis in glioma
Feng Wang, Jianhe Yue, Maoxin Zhang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Page 1

Scroll to top